Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

USA joins Canada, UK, Ireland and Austria in allowing people with insulin-treated diabetes to fly commercial aircraft.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Impact of severe hypoglycaemia on psychological outcomes in adults with Type 2 diabetes: a systematic review.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Postpartum hypoglycaemia is common in the immediate postpartum period in Type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Self-Reported Frequency and Impact of Non-Severe Hypoglycaemia in Insulin-Treated Adults in the UK.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same journal

Relationship Between hsCRP, Glycaemic Control and Response to Sotagliflozin in Type 1 Diabetes: A Post Hoc Analysis of the inTandem3 Trial.

Diabetes, obesity & metabolism·2026
Same journal

Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies.

Diabetes, obesity & metabolism·2026
Same journal

First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial.

Diabetes, obesity & metabolism·2026
Same journal

Trends in Prevalence of Diabetes, Pre-Diabetes, and Cardiometabolic Risk Factor Control Among U.S. Adults, 2013-2023.

Diabetes, obesity & metabolism·2026
Same journal

Metabolic Risk-Attributable Dementia Burden: A Life-Course and Cautious Attribution Perspective.

Diabetes, obesity & metabolism·2026
Same journal

A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at Baseline.

Diabetes, obesity & metabolism·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Diabetes and driving.

B Inkster1, B M Frier

  • 1Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, UK. berit.inkster@luht.scot.nhs.uk

Diabetes, Obesity & Metabolism
|January 29, 2013
PubMed
Summary
This summary is machine-generated.

Hypoglycaemia in insulin-treated drivers can impair driving. While diabetes may slightly increase accident risk, frequent glucose monitoring and updated EU driving regulations aim to ensure safety for diabetic drivers.

Keywords:
diabetesdrivingdriving licenceinsulinmotor vehicle accidentsulphonylurea

More Related Videos

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Related Experiment Videos

Last Updated: May 14, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Area of Science:

  • Medical safety
  • Road safety
  • Diabetes management

Background:

  • Hypoglycaemia is a primary safety concern for individuals driving on insulin or insulin secretagogues, as it impairs driving performance.
  • Other diabetes complications like visual impairment and peripheral neuropathy also affect driving fitness.
  • Existing studies on diabetic drivers' accident risk are often limited and of poor quality, suggesting a modestly increased but acceptable risk.

Purpose of the Study:

  • To review the safety concerns and risks associated with driving for individuals with diabetes, particularly those using insulin.
  • To examine factors influencing driving risk in diabetic individuals.
  • To discuss the impact of European Union driving directives on licensing for people with diabetes.

Main Methods:

  • Review of case-control studies and existing literature on diabetes and driving safety.
  • Analysis of factors contributing to increased driving risk, such as severe hypoglycaemia and glycaemic control.
  • Examination of regulatory changes in driving licence policies for diabetic individuals in Europe.

Main Results:

  • Drivers with diabetes may have a slightly elevated, yet acceptable, risk of motor vehicle accidents.
  • Factors increasing risk include prior severe hypoglycaemia, hypoglycaemia while driving, strict glycaemic control (lower HbA1c), and lack of pre-drive glucose monitoring.
  • Frequent blood glucose testing can mitigate impaired awareness of hypoglycaemia.

Conclusions:

  • Updated EU driving regulations have led to revised licensing criteria for diabetic drivers.
  • Stricter rules apply to Group 1 licences, while Group 2 licences have seen relaxation, allowing insulin-treated drivers to apply under stringent UK criteria with a 1-year renewable licence.
  • Managing hypoglycaemia risk through frequent monitoring is crucial for diabetic individuals who drive.